Carl Zeiss Meditec (ETR:AFX – Get Rating) received a €210.00 ($225.81) price target from equities researchers at Deutsche Bank Rese… in a report released on Tuesday, Borsen Zeitung reports. Deutsche Bank Rese…’s price target suggests a potential upside of 62.79% from the company’s previous close.
AFX has been the subject of a number of other reports. UBS Group set a €170.00 ($182.80) price target on Carl Zeiss Meditec in a research note on Wednesday, March 16th. HSBC set a €146.00 ($156.99) price target on Carl Zeiss Meditec in a research note on Monday, February 14th. Deutsche Bank Aktiengesellschaft set a €210.00 ($225.81) price target on Carl Zeiss Meditec in a research note on Monday, February 14th. Finally, Hauck and Aufhaeuser set a €215.00 ($231.18) price target on Carl Zeiss Meditec in a research note on Monday, February 14th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, Carl Zeiss Meditec currently has a consensus rating of “Hold” and a consensus target price of €177.78 ($191.16).
AFX stock traded down €0.95 ($1.02) on Tuesday, reaching €129.00 ($138.71). The company’s stock had a trading volume of 62,608 shares, compared to its average volume of 94,405. Carl Zeiss Meditec has a 52 week low of €118.10 ($126.99) and a 52 week high of €202.00 ($217.20). The company has a market capitalization of $11.54 billion and a P/E ratio of 50.81. The firm has a fifty day moving average of €139.41 and a two-hundred day moving average of €157.91. The company has a debt-to-equity ratio of 7.23, a current ratio of 3.58 and a quick ratio of 2.90.
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and solutions for the diagnosis and treatment of eye diseases; and systems and consumables for cataract, retinal, and refractive surgeries.
- Institutional Buying Puts A Bottom In Manpower Group Inc
- Workhorse Johnson & Johnson Plows New All-Time Highs
- Fastenal Stock is Ready to Sprint Higher
- J.B. Hunt Transportation Services Fires On All Cylinders
- 3 No-Brainer Stocks to Buy with $1000
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.